Letters

Influence of cholesterol on survival after stroke

BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7116.1158 (Published 01 November 1997) Cite this as: BMJ 1997;315:1158

Beneficial effects of cholesterol lowering on atherosclerosis may not lessen with age

  1. Nicholas Stoy, Senior medical officera
  1. a Royal Hospital for Neuro-disability, London SW15 3SW
  2. b Royal Bolton Hospital, Bolton BL4 0JR
  3. c Birmingham Heartlands Hospital, Birmingham B9 5SS
  4. d University of Buenos Aires, Faculty of Medicine, Hospital de Clinicas José de San Martin, Cordoba 2351, Buenos Aires, Argentina
  5. e Clinica Neurologica, Dipartimento di Medicina Interna e Sanita Pubblica, Universita degli Studi di L'Aquila, Ospedale S Maria di Collemaggio, 67100 L'Aquila-Collemaggio, Italy
  6. f Acute Stroke Unit and Cerebrovascular Clinic, University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow G11 6NT

    Editor—In their study of survival after stroke Alexander G Dyker and colleagues showed that serum cholesterol concentration is inversely correlated with degree of disability and all cause mortality in a clinically heterogeneous group of elderly patients with stroke.1 Interesting though these findings are, they are likely to have only a tenuous connection with the study's stated objective of investigating the association between cholesterol concentration and cerebrovascular disease. As the authors hint in their introduction, the most consistent and direct evidence about the aetiology of stroke may come from postmortem examinations rather than clinical diagnostic groupings, even when supported by the best available brain imaging techniques.

    The Akita pathology study, to which the authors refer, established a link between high cholesterol concentrations, cortical artery infarction, and widespread atherosclerosis in predominantly larger basal cerebral arteries (1.5-6.0 mm). Low cholesterol concentrations and minimal atherosclerosis were generally associated with cerebral haemorrhage, except for somewhat higher cholesterol concentrations and a substantial incidence of atherosclerosis in those with cerebral haemorrhage aged over 65. Intermediate levels of cholesterol and atherosclerosis were found in cases of penetrating artery infarction. Suspected cardioembolic strokes were classified separately.2

    If these pathophysiological correlates are accepted, the authors need not invoke novel biological mechanisms to explain their results.3 Rather, if cholesterol is a crude marker for atherosclerosis, their data support the proposition that, in the age group studied, strokes related to atherosclerosis, presumably including some cases of cerebral haemorrhage, have a better prognosis than strokes related to other causes (notably arteriosclerosis).4 Recent evidence suggests that if the atherosclerotic group can be specifically targeted with lipid (low density lipoprotein cholesterol) lowering drugs before severe damage has occurred, a significant impact on stroke is achievable. Pooled data from four pravastatin atherosclerosis regression trials (coronary or carotid) indicated a reduction in the …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe